Celltrion and Celltrion Healthcare to Acquire Treasury Shares Worth 500 Billion KRW

All-Out Effort to Enhance Shareholder Value

Celltrion Group announced on the 8th that Celltrion and Celltrion Healthcare completed a buyback of treasury shares worth 500 billion KRW on the 7th.

On the 23rd of last month, Celltrion Group decided to acquire a total of 2,426,161 shares of Celltrion (acquisition amount 365.1 billion KRW) and 2,440,000 shares of Celltrion Healthcare (acquisition amount 164.4 billion KRW). Subsequently, within 11 business days, they completed the acquisition of treasury shares worth a total of 529.5 billion KRW. This year alone, the two companies purchased a total of 669.4 billion KRW worth of 4,428,402 shares of Celltrion and 282.7 billion KRW worth of 4,345,000 shares of Celltrion Healthcare, totaling 952.1 billion KRW in treasury shares.

The two companies plan to continue additional efforts to enhance shareholder value while monitoring market conditions.

Along with this, Celltrion Holdings supported the merger of Celltrion Group by announcing the acquisition of Celltrion shares on the 7th. Celltrion Holdings has continuously acquired Celltrion shares through on-market purchases in the past. They plan to consider additional acquisitions depending on market conditions. Celltrion Holdings views the purchase of Celltrion shares as a way to strengthen its control over the integrated Celltrion as a holding company and to facilitate the smooth merger of Celltrion and Celltrion Pharm in the future.

Celltrion Group has previously stated that as the first step of the merger, Celltrion will first absorb and merge Celltrion Healthcare, followed by the merger of the integrated Celltrion and Celltrion Pharm, aiming to enhance synergy between the bio and chemical businesses and establish itself as a global comprehensive biotechnology company.

Despite the smooth progress of Celltrion Group’s business, the market value of the companies remains undervalued due to market uncertainties. The group-level acquisition of treasury and affiliate shares is expected to serve as a signal reaffirming confidence in the future growth potential of the integrated Celltrion to the market.

Meanwhile, Celltrion recorded its highest-ever quarterly sales and operating profit, and Celltrion Healthcare also posted its highest quarterly sales in history.

A representative of Celltrion Group said, “The active purchase of treasury and affiliate shares reflects the group’s firm commitment to a successful merger and future growth. The acquired shares will be used for investments to secure future growth engines, strengthen business competitiveness, and will be continuously utilized to promote the development of the integrated Celltrion and enhance shareholder value.”

This content was produced with the assistance of AI translation services.